Peiman Hematti, MD, is the director of Clinical Hematopoietic Cell Processing Laboratory at UW-Madison. Much of his research is aimed at improving post-transplant immunological complications, such as graft-versus-host disease. But Hematti and his team are also working to develop and test new cellular therapies for cancer treatment.
His lab’s ability to do that took a giant step forward in late 2020 when they received word from FACT – the Foundation for the Accreditation of Cellular Therapy – that the lab had received certification to do “more than minimal cell manipulation.”
“This is a big deal,” Hematti said. “We are the only lab on campus that has this accreditation, which is the culmination of years of working hard and proving that we can do it right and credit goes to our entire team and especially our senior cell therapy lab specialists.”Read the full article at: https://www.uwhealth.org/news/the-spirit-of-innovation-pushing-the-boundaries-of-cell-therapy-to-help-cancer-patients?fbclid=IwAR0wv7bXgGITdAxQaRD_iarE6vq0UrfBIWetAYMWXl8M9Hr0fX0rfVKltEQ